UniProt ID | MTA1_RAT | |
---|---|---|
UniProt AC | Q62599 | |
Protein Name | Metastasis-associated protein MTA1 | |
Gene Name | Mta1 | |
Organism | Rattus norvegicus (Rat). | |
Sequence Length | 703 | |
Subcellular Localization |
Isoform 1: Nucleus. Nucleus envelope . Cytoplasm. Cytoplasm, cytoskeleton. Associated with microtubules. Localization at the nuclear envelope is TPR-dependent (By similarity).. Isoform 2: Rough endoplasmic reticulum. Golgi apparatus. Cytoplasmic ves |
|
Protein Description | Transcriptional coregulator which can act as both a transcriptional corepressor and coactivator. As a part of the histone-deacetylase multiprotein complex (NuRD), regulates transcription of its targets by modifying the acetylation status of the target chromatin and cofactor accessibility to the target DNA. In conjunction with other components of NuRD, acts as a transcriptional corepressor of BRCA1, ESR1, TFF1 and CDKN1A. Acts as a transcriptional coactivator of BCAS3, PAX5 and SUMO2, independent of the NuRD complex. Stimulates the expression of WNT1 by inhibiting the expression of its transcriptional corepressor SIX3. Regulates p53-dependent and -independent DNA repair processes following genotoxic stress. Regulates the stability and function of p53/TP53 by inhibiting its ubiquitination by COP1 and MDM2 thereby regulating the p53-dependent DNA repair. Plays an important role in tumorigenesis, tumor invasion, and metastasis. Plays a role in the regulation of the circadian clock and is essential for the generation and maintenance of circadian rhythms under constant light and for normal entrainment of behavior to light-dark (LD) cycles. Positively regulates the CLOCK-ARNTL/BMAL1 heterodimer mediated transcriptional activation of its own transcription and the transcription of CRY1. Regulates deacetylation of ARNTL/BMAL1 by regulating SIRT1 expression, resulting in derepressing CRY1-mediated transcription repression (By similarity). Isoform 2 may be involved in the sorting of amylase during zymogen granule formation in the pancreas. With Tfcp2l1, promotes establishment and maintenance of pluripotency in embryonic stem cells (ESCs) and inhibits endoderm differentiation (By similarity).. | |
Protein Sequence | MAANMYRVGDYVYFENSSSNPYLIRRIEELNKTANGNVEAKVVCFYRRRDISSSLIALADKHATLSVCYRAGPGADTGEEGEVEEEVENPEMVDLPEKLKHQLRHRELFLSRQLESLPATHIRGKCSVTLLNETESLKSYLEREDFFFYSLVYDPQQKTLLADKGEIRVGNRYQADITDLLKDGEEDGRDQSKLETKVWEAHNPLVDKQIDQFLVVARSVGTFARALDCSSSVRQPSLHMSAAAASRDITLFHAMDTLHKNIYDISKAISALVPQGGPVLCRDEMEEWSASEANLFEEALEKYGKDFTDIQQDFLPWKSLTSIIEYYYMWKTTDRYVQQKRLKAAEAESKLKQVYIPNYNKPNPNQISVNSVKASVVNGTGTPGQSPGAGRACESCYTTQSYQWYSWGPPNMQCRLCASCWTYWKKYGGLKMPTRLDGERPGPNRNNMSPHGIPARSSGSPKFAMKTRQAFYLHTTKLTRIARRLCREILRPWHAARHPYMPINSAAIKAECTARLPEASQSPLVLKQVVRKPLEAVLRYLETHPRPPKPDPVKSSSSVLSSLTPAKSAPVINNGSPTILGKRSYEQHNGVDGLANHGQTRHMGPSRNLLLNGKSYPTKVRLIRGGSLPPVKRRRMNWIDAPDDVFYMATEETRKIRKLLSSSETKRAARRPYKPIALRQSQALPLRPPPPAPVNDEPIVIED | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
52 | Phosphorylation | FYRRRDISSSLIALA EEECCCCCHHHHHHH | 20.40 | 28432305 | |
53 | Phosphorylation | YRRRDISSSLIALAD EECCCCCHHHHHHHH | 29.51 | 28432305 | |
54 | Phosphorylation | RRRDISSSLIALADK ECCCCCHHHHHHHHH | 19.60 | 27097102 | |
380 | Phosphorylation | KASVVNGTGTPGQSP EEEEECCCCCCCCCC | 32.45 | 23984901 | |
382 | Phosphorylation | SVVNGTGTPGQSPGA EEECCCCCCCCCCCC | 24.88 | 28689409 | |
386 | Phosphorylation | GTGTPGQSPGAGRAC CCCCCCCCCCCCCCC | 31.08 | 27097102 | |
449 | Phosphorylation | GPNRNNMSPHGIPAR CCCCCCCCCCCCCCC | 18.83 | 23712012 | |
520 | Phosphorylation | TARLPEASQSPLVLK HHCCCHHHCCCCHHH | 29.54 | 27097102 | |
522 | Phosphorylation | RLPEASQSPLVLKQV CCCHHHCCCCHHHHH | 20.08 | 27097102 | |
561 | Phosphorylation | KSSSSVLSSLTPAKS CCCHHHHHHCCCCCC | 22.58 | 28432305 | |
562 | Phosphorylation | SSSSVLSSLTPAKSA CCHHHHHHCCCCCCC | 31.91 | 28432305 | |
564 | Phosphorylation | SSVLSSLTPAKSAPV HHHHHHCCCCCCCCC | 24.13 | 27097102 | |
576 | Phosphorylation | APVINNGSPTILGKR CCCCCCCCCCCCCCC | 22.46 | 23712012 | |
578 | Phosphorylation | VINNGSPTILGKRSY CCCCCCCCCCCCCCH | 30.45 | 27097102 | |
583 | Methylation | SPTILGKRSYEQHNG CCCCCCCCCHHCCCC | 42.55 | 26494469 | |
614 | Acetylation | RNLLLNGKSYPTKVR CCEEECCCCCCCEEE | 45.82 | - | |
624 | Methylation | PTKVRLIRGGSLPPV CCEEEEEECCCCCCC | 48.27 | 26494463 | |
627 | Phosphorylation | VRLIRGGSLPPVKRR EEEEECCCCCCCCCC | 40.29 | 25403869 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of MTA1_RAT !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of MTA1_RAT !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MTA1_RAT !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of MTA1_RAT !! |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...